For biotechnology companies, the path towards commercialising a drug is torturously long and extraordinarily expensive. And while drug compa…
For biotechnology companies, the path towards commercialising a drug is torturously long and extraordinarily expensive. And while drug compa…
General medical practitioners (GPs) are primary caregivers and the first point of contact in the medical system. They do not require a r…
Sydney dentist and entrepreneur Dr David Penn has sold a majority stake in his business Southern Cross Dental Laboratories to a private equi…
Kathryn Anderson started up Viva Physiotherapy in order to create the sort of physiotherapy business that she wanted to work in. Kathryn …
The Australian pharmaceutical sector commands an important position in the domestic economy. A knowledge-based, skill- and technology-intens…
The Australian distributor of the controversial Power Balance wristbands will be placed into receivership today, with the owner of the busin…
A biotechnology company that focuses on the area of digestive diseases and Perth’s tallest residential tower are the latest victims of the s…
The founder of Pan Pharmaceuticals, Jim Selim, has died at the age of 68, but a Federal Court class action over the Federal Government’s rol…
After a difficult 18 months for the Australian biotechnology sector, Melbourne-based drug developer Acrux has boosted the industry’s confide…
A South Australian manufacturer, a hospital group with operations in New South Wales, Victoria and Queensland and a resort in the Blue Mount…
Profit margins and investment returns in Australia’s aged care sector have shrunk so far that an industry expert has believes the entire sec…
Struggling Melbourne anti-HIV drug developer Narhex Life Sciences has been placed in administration after a long battle for survival, three …
